Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 4
2006 2
2007 2
2008 1
2009 1
2010 3
2011 3
2012 5
2013 4
2014 1
2015 3
2016 4
2017 4
2018 3
2019 4
2020 4
2021 4
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative.
Luque J, Mendes I, Gómez B, Morte B, López de Heredia M, Herreras E, Corrochano V, Bueren J, Gallano P, Artuch R, Fillat C, Pérez-Jurado LA, Montoliu L, Carracedo Á, Millán JM, Webb SM, Palau F; CIBERER Network; Lapunzina P. Luque J, et al. Clin Genet. 2022 May;101(5-6):481-493. doi: 10.1111/cge.14113. Epub 2022 Feb 4. Clin Genet. 2022. PMID: 35060122 Free PMC article. Review.
Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
Ruiz-Llorente L, Gallardo-Vara E, Rossi E, Smadja DM, Botella LM, Bernabeu C. Ruiz-Llorente L, et al. Among authors: botella lm. Expert Opin Ther Targets. 2017 Oct;21(10):933-947. doi: 10.1080/14728222.2017.1365839. Epub 2017 Aug 20. Expert Opin Ther Targets. 2017. PMID: 28796572 Free article. Review.
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?
Dupuis-Girod S, Shovlin CL, Kjeldsen AD, Mager HJ, Sabba C, Droege F, Fargeton AE, Fialla AD, Gandolfi S, Hermann R, Lenato GM, Manfredi G, Post MC, Rennie C, Suppressa P, Sure U; ePag group; Buscarini E. Dupuis-Girod S, et al. Eur J Med Genet. 2022 Oct;65(10):104575. doi: 10.1016/j.ejmg.2022.104575. Epub 2022 Aug 5. Eur J Med Genet. 2022. PMID: 35940549 Free article.
Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth.
Cabrera-Montes J, Aguirre DT, Viñas-López J, Lorente-Herraiz L, Recio-Poveda L, Albiñana V, Pérez-Pérez J, Botella LM, Cuesta AM. Cabrera-Montes J, et al. Among authors: botella lm. Acta Neurochir (Wien). 2023 Dec;165(12):4241-4251. doi: 10.1007/s00701-023-05825-x. Epub 2023 Oct 16. Acta Neurochir (Wien). 2023. PMID: 37843608 Free PMC article.
A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2.
Errasti Díaz S, Peñalva M, Recio-Poveda L, Vilches S, Casado-Vela J, Pérez Pérez J, Botella LM, Albiñana V, Cuesta AM. Errasti Díaz S, et al. J Clin Med. 2022 May 28;11(11):3053. doi: 10.3390/jcm11113053. J Clin Med. 2022. PMID: 35683441 Free PMC article.
The Endothelial Landscape and Its Role in Von Hippel-Lindau Disease.
de Rojas-P I, Albiñana V, Taranets L, Recio-Poveda L, Cuesta AM, Popov N, Kronenberger T, Botella LM. de Rojas-P I, et al. Among authors: botella lm. Cells. 2021 Sep 4;10(9):2313. doi: 10.3390/cells10092313. Cells. 2021. PMID: 34571962 Free PMC article.
57 results